Milestone Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Milestone Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Milestone Pharmaceuticals Inc
Rating: 1.07650
Author: Trendlyne DVM scores

about

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-admini...

1.21 -0.03 (-2.42%)

60.46% Fall from 52W High

618.5K

XNAS Volume

XNAS 17 Jul, 2026 3:07 PM (EDT)

Not Eligible

Expensive Valuation

9.0 / 100

Technically Bearish

34.1 / 100

1Yr Price target upside is 423%

6 analysts

Milestone Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Milestone Pharma Inc Live Stock Price Today, Share Analysis and Chart

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-admini...

60.46% Fall from 52W High

SWOT Analysis

Milestone Pharma Inc Live Price Chart

Milestone Pharma Inc Live Price Chart